Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 27 Carcinoma, Non-Small-Cell Lung 27 Brain Neoplasms 23 Lung Neoplasms 17 Neoplasm Metastasis 15 Breast Neoplasms 12 Melanoma 9 Carcinoma, Renal Cell 8 Pancreatic Neoplasms 7 Colorectal Neoplasms 6 Carcinoma, Hepatocellular 5 Urinary Bladder Neoplasms 3 Neoplasms 3 NSCLC 3 Meningioma 3 Gastrointestinal Neoplasms 3 Unresectable Locally Recurrent Rectal Cancer 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Spinal Cord Compression 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Epidural Neoplasms 2 Carcinoma, Transitional Cell 2 Adenocarcinoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1

Interventions

Prednisone 2 Abiraterone Acetate 2 fludrocortisone acetate 1 enzalutamide 1 darolutamide 1 apalutamide 1 Standard of Care 1 Radiosurgery 1 Hydrocortisone 1 Docetaxel 1 Dexamethasone 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Metastatic × Radiosurgery × 90 days × Clear all

NCT03784755 2026-03-27

PLATON

Canadian Cancer Trials Group

Phase NA Active not recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡